No registrations found.
ID
Source
Health condition
pre-eclampsia
Sponsors and support
Atrium Medisch Centrum Parkstad
Intervention
Outcome measures
Primary outcome
Difference between pregnant women with and without pre-eclampsia for the biomarkers sFlt-1, PlGf and ratio.
Secondary outcome
1. Is the value of sFlt-1, PlGf and ratio a prognostic measure to assess severity of the disease?
2. Can these markers be used to make a desiscion on management of the pregnant women (estrictive vs. proactive).
Background summary
N/A
Study objective
What is the contribution of the serum markers sFlT-1 and PlGF in the diagnosis and management of pre-eclampsia.
Study design
Only one bloodsample at time of admission.
Intervention
N/A
M.T.M. Raijmakers
Laboratory for Clinical Chemistry & Haematology
Atrium Medisch Centrum Parkstad
Heerlen 6401 CX
The Netherlands
+31 (0)45 5766340
mraijmakers@atriummc.nl
M.T.M. Raijmakers
Laboratory for Clinical Chemistry & Haematology
Atrium Medisch Centrum Parkstad
Heerlen 6401 CX
The Netherlands
+31 (0)45 5766340
mraijmakers@atriummc.nl
Inclusion criteria
Case:
Pregant women with suspected pre-eclampsia.
Control:
Pregnant women admitted for a primary C. section.
Exclusion criteria
Case:
1. Pre-existing hypertension.
Control:
1. Presence of contractions;
2. Pre-existing hypertension.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL2418 |
| NTR-old | NTR2526 |
| Other | METC Atrium-Orbis-Zuyd : 10-N-78 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |